Maintaining the normal function of the pulmonary microvascular barrier is critical for ARDS treatment. To assess the relationship between the HAS2 protein level, HA content and the clinical prognosis of ARDS in patients with ARDS. Compare the HAS2 protein levels, HMW-HA and LMW-HA levels, endothelial injury indicators, and lungs in the blood of severe and non-ARDS severe patients and healthy adults admitted to the ICU. The correlation between permeability, disease severity and prognosis to explore the predictability of HAS2-HA on the clinical outcome of ARDS.
Study Type
OBSERVATIONAL
Enrollment
60
28-day fatality Rate
28-day mortality (patients will be followed for 28 days)
Time frame: 28 days after enrollment
90-day fatality rate
90-day mortality (patients will be followed for 90 days)
Time frame: 90 days after enrollment
ICU hospital stay
Length of ICU stay
Time frame: through study completion, an average of 4 week
ICU fatality rate
The ratio of the total number of deaths from all causes of the enrolled patients during ICU hospitalization.
Time frame: through study completion, an average of 4 week
Wearing time from mechanical ventilation
successful weaning defined as the absence of the requirement for ventilatory support, without reintubation
Time frame: through study completion,an average of 4 week
Peripheral blood HMW-HA and LMW-HA levels
ELISA method to separate and detect HMW-HA and LMW-HA levels(Units of Measure unit nM/ml)
Time frame: 0, 1, 3, 7 days after enrollment
HAS2 protein content in peripheral blood
ELISA method detects HAS2 protein in peripheral blood
Time frame: 0, 1, 3, 7 days after enrollment
ENOS, ET-1, vWF levels in peripheral blood
ELISA method to detect eNOS, ET-1, vWF in peripheral blood to evaluate endothelial cell damage(Measure unit ng/ml)
Time frame: 0, 1, 3, 7 days after enrollment
Levels of bound mucinoglycans-1, nitric oxide, and acetylheparin sulfate in peripheral blood
glycocalyx levels of the endothelium were assessed by measuring the levels of mucin polysaccharide-1, nitric oxide and acetyl heparan sulfate in peripheral blood by ELISA assay(Measure unit ng/ml)
Time frame: 0, 1, 3, 7 days after enrollment
In peripheral blood, IL-1α, IL-6, neutrophils, lymphocytes, descending Procalcin, C-reactive protein value
The ELISA method detects IL-1α and IL-6 in the blood, and records the blood neutrophils, lymphocytes, and vary in procalcin and C-reactive protein to assess the inflammatory response of ARDS(Measure unit pg/ml)
Time frame: 0, 1, 3, 7 days after enrollment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.